Next Big Innovation Labs
- Company typePrivate
- Founded2016
- HeadquartersBengaluru, India
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
Next Big Innovation Labs firmographics
Firmographics- Name
- Next Big Innovation Labs
- Website
- https://nextbiglab.com
- Company type
- Private
- Founded year
- 2016
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Where Next Big Innovation Labs is headquartered
LocationHeadquarters
- HQ city
- Bengaluru
- HQ country
- India
- HQ region
- Asia
Markets served
Next Big Innovation Labs business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Operations
Next Big Innovation Labs product offering
Product offeringCore offering
Next Big Innovation Labs develops 3D bioprinting technologies and products targeted at addressing medical organ demand. The company operates in the regenerative medicine and biomedical engineering space, building bioprinting solutions for healthcare and research applications.
Differentiator
Problem solved
Functional benefit
Products and services
- 3D Bioprinting Technology and Products 3D bioprinting technologies and products designed to address medical organ demand, targeted at healthcare and medical research organizations for regenerative medicine and tissue engineering applications.
Companies that use Next Big Innovation Labs
Customer profileIdeal customer profiles1 record
Next Big Innovation Labs technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Next Big Innovation Labs partnerships and signals
Strategic signalRecent moves2 records
Next Big Innovation Labs competitors and assessment
Company assessmentEmerging players
- Modern Meadow: Biofabrication company using engineered proteins and tissue platforms for materials and biomedical applications. Comparable as a biofabrication-focused emerging player with adjacent regenerative-medicine ambitions.
- Poietis: Laser-assisted 3D bioprinting company developing tissue constructs for regenerative medicine. Comparable as an emerging, niche bioprinting platform with similar translational ambition.
Broad incumbents
- Stratasys: Global 3D printing incumbent with biomedical offerings. Comparable as a broad incumbent shaping the addressable market for additive manufacturing in healthcare.
- 3D Systems: Large, established 3D printing incumbent with a healthcare/bioprinting arm (including Allevi). Comparable as the broader incumbent that defines competitive pricing and distribution in the same category.
Direct peers
- Aspect Biosystems: Developer of microfluidic 3D bioprinting platforms and tissue therapeutics for metabolic and endocrine diseases. Directly comparable as a bioprinting platform company targeting medical organ/tissue demand.
- regenHU: Swiss bioprinting hardware and bioink provider for tissue engineering and regenerative medicine. Comparable as a smaller, specialist bioprinter vendor with overlapping customer base.
- CELLINK (BICO Group): Global leader in 3D bioprinting hardware, bioinks, and consumables. Directly comparable to NBIL as a bioprinter-and-bioink platform serving academic and clinical researchers.
- Allevi (a 3D Systems company): 3D bioprinters and bioinks for life science research; now part of 3D Systems. Directly comparable bioprinting product line and academic/clinical go-to-market.
- Organovo: Pioneer in 3D-printed human tissue for therapeutic and research use. Closely comparable mission of building printable human tissue to address organ demand and disease modeling.
Regional players
- Pandorum Technologies: India-based biotech developing 3D-printed bio-tissues and organoids for medical R&D. Most direct Indian regional peer to NBIL, sharing geography, talent pool, and translational tissue-engineering focus.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat1 record
Key risks5 records
Key highlights4 records
Customer concentration
Next Big Innovation Labs social profiles
Digital presenceNext Big Innovation Labs financial estimates
Financial estimateRevenue estimate
Valuation estimate
Next Big Innovation Labs leadership team
Management profileNumber of profiles
Profiles2 records
Next Big Innovation Labs funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Next Big Innovation Labs M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Next Big Innovation Labs
What does Next Big Innovation Labs do?
Next Big Innovation Labs develops 3D bioprinting technologies and products targeted at addressing medical organ demand. The company operates in the regenerative medicine and biomedical engineering space, building bioprinting solutions for healthcare and research applications.
When was Next Big Innovation Labs founded?
Next Big Innovation Labs was founded in 2016. It employs 11 to 50 people.
Where is Next Big Innovation Labs based?
Next Big Innovation Labs is headquartered in Bengaluru, India, in the Asia region.
Who are Next Big Innovation Labs's main competitors?
Emerging players on record are Modern Meadow and Poietis. Broad incumbents are Stratasys and 3D Systems. Direct peers are Aspect Biosystems, regenHU, CELLINK (BICO Group), Allevi (a 3D Systems company) and Organovo. Pandorum Technologies is listed as a regional player.
Does Next Big Innovation Labs have an API?
No public API is recorded for Next Big Innovation Labs.